← Back to all signals
RESEARCH PAPER ANALYSIS

Assessment of out-of-field radiation dose in proton therapy by combining in-phantom measurements with different passive detectors.

AI interpretation is pending for this paper.

Open original publication →
PMID41500019
JournalPhysica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Publication Date2026-01-06
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: Proton therapy is an advanced radiotherapy technique that reduces radiation exposure to healthy tissues while maintaining tumor control. However, out-of-field radiation dose remains a concern due to their potential contribution to secondary cancer risks, particularly in pediatric patients and in the fetus of pregnant patients. Accurate assessment of out-of-field dose is challenging due to the mixed radiation field composed of neutrons, protons, electrons, photons, and alphas with a wide energy range. METHODS: This study investigates how in-phantom measurements with lithium fluoride (LiF) MTS (LiF:Mg,Ti) and MCP (LiF:Mg,Cu,P) thermoluminescent detectors (TLDs) with different concentrations of 6Li and 7Li and bubble detectors (BD-PNDs) can be combined to assess total out-of-field dose in proton therapy. A previous measurement campaign, during which a five-year-old phantom was treated for a brain tumor, was used as a representative case. The out-of-field dose and detector response for this case were modelled by combining Monte Carlo radiation transport simulations, fluence to dose conversion factors and detector response functions. RESULTS AND CONCLUSIONS: The modelled and experimental measurements were in good agreement, considering the limitations of the simulations. The results of this study demonstrated that MTS-7 and MCP-7 detectors with 99.9% 7Li enrichment can provide a good estimate of the absorbed dose to water and dose equivalent from all particles excluding neutrons, while BD-PNDs can provide a reasonable estimate of the neutron dose equivalent. Combining MTS-7 or MCP-7 TLDs with BD-PNDs thus allows to get a complete picture of the out-of-field dose in proton therapy by in-phantom measurements.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Preference of Traditional Chinese Medicine Service Utilization Among Cancer Patients in China: A Discrete Choice Experiment. Integrative cancer therapies 63.4 2 Insights from strengthening perinatal hepatitis b prevention in healthcare facilities in Delta State, Nigeria: A prospective, pilot implementation intervention. Sage open chronic disease 63.4 3 Osteoid Osteoma Mimicking Brachial Plexopathy in a Child. Oman medical journal 60.0 4 The adjunctive use of Bifidobacterium Quadruple Viable Bacteria with interferon in pediatric acute enteritis: inhibition of gut hormones, pain mediators, and systemic inflammation. American journal of translational research 66.0 5 Balloon-Assisted Squid 12 Embolization of a Renal Angiomyolipoma With Imaging Findings Suggestive of Arteriovenous Communication: A Technical Report. Cureus 57.5 6 Advanced Paternal Age: Implications on Fertility, Pregnancy Outcomes, and Offspring Health. The journal of obstetrics and gynaecology research 71.5 7 Long-Term or Recurrent Antibiotic Use During Childhood or Adolescence and the Risk of Kidney Cancer: A Cohort Study. Cancer medicine 64.0 8 Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection. Pediatric gastroenterology, hepatology & nutrition 63.25 9 Integrative network toxicology and transcriptomic analyses identify DCP1B and HAS2 as key prognostic biomarkers in formaldehyde-associated Wilms tumor. The Journal of international medical research 61.05 10 Programmed cell death evasion in BRAF V600E-driven primary CNS tumors and thyroid cancer brain metastases. Frontiers in neurology 56.0 11 Mycosis fungoides in a Mexican pediatric series: Clinical, immunophenotypic, and therapeutic features. Revista medica del Instituto Mexicano del Seguro Social 64.14 12 [Dermatoscopic "sky full of stars" pattern in a congenital melanocytic nevus with follicular distribution]. Revista medica del Instituto Mexicano del Seguro Social 47.5 13 MGA::NUTM1 fusion sarcoma: expanding the spectrum of NUT-rearranged sarcomas with extensive review of the literature. American journal of clinical pathology 69.1 14 Clinical and pathological characteristics of congenital neuroblastoma in 15 Chinese infants: a retrospective analysis from a single-center. Frontiers in medicine 62.6 15 Single-cell transcriptomic analysis reveals fatty acid metabolic heterogeneity and identifies DKK1 as a candidate prognostic factor in osteosarcoma. Frontiers in endocrinology 65.5 16 Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study. Frontiers in pharmacology 72.86 17 Impaired bone health after pediatric acute lymphoblastic leukemia treatment despite normal DXA: insights from high-resolution peripheral quantitative computed tomography. Frontiers in endocrinology 65.84 18 The success-failure inversion in modern medicine. Frontiers in public health 60.5 19 High prevalence of gonadal dysfunction in pediatric sarcoma survivors: insights from hormonal and clinical markers. Frontiers in pediatrics 67.1 20 Rule-derived preoperative inflammatory-lymphocyte recovery phenotype and pathological response in resected osteosarcoma: a retrospective cohort study. Frontiers in immunology 76.62 21 Advances in tumor necrosis factor-α inhibitors for the treatment of juvenile idiopathic arthritis-associated uveitis. Frontiers in immunology 70.2 22 Amphotericin B Colloidal Dispersion Is Effective and Safe for the Treatment of Invasive Aspergillosis in Chinese Patients with Hematologic Disease: A Multicenter, Prospective, Observational, Real-World Study. Drug design, development and therapy 73.34 23 Time of diagnosis of congenital upper limb anomalies: a cohort study of 703 patients from a local registry in Norway. Acta orthopaedica 63.5 24 Health risk assessment of radon concentrations and water quality parameters in drinking well water of Erbil villages. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 58.7 25 Manufacturing cost analysis and exploratory economic evaluation of natural killer cell immunotherapy for paediatric solid tumors. Clinical & translational immunology 68.52 26 Large Undifferentiated Sarcoma of the Liver: A Rare Case Report and Literature Review. Clinical case reports 47.4 27 Beyond Immediate Release: FDM-Printed Pediatric 6-Mercaptopurine Chewable Tablets with Spontaneous In Situ Nanostructure Formation. AAPS PharmSciTech 63.4 28 Children's participation in assent to paediatric oncology research: experiences of children, siblings and parents. Trials 58.5 29 Single and multiple oral giant cell fibromas: a case report and review of the literature. Journal of medical case reports 53.0 30 Heavy Metal Concentrations and Health Risk Assessment of Melon Seeds (Citrullus lanatus) From Selected Markets in Ghana. International journal of food science 56.0 31 Role-play in graduate genetic counseling education: a practicum experience in South Korea. Ewha medical journal 56.0 32 Family-centred psycho-oncological counselling for parents with cancer: a longitudinal secondary data analysis of psychological distress, family functioning and parental concerns. BMC cancer 59.5
PATIENT-FRIENDLY SUMMARY

Assessment of out-of-field radiation dose in proton therapy by combining in-phantom measurements with different passive detectors.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic